Sumitomo Pharma Balance Sheet Health
Financial Health criteria checks 1/6
Sumitomo Pharma has a total shareholder equity of ¥160.9B and total debt of ¥390.1B, which brings its debt-to-equity ratio to 242.4%. Its total assets and total liabilities are ¥868.9B and ¥708.0B respectively.
Key information
242.4%
Debt to equity ratio
JP¥390.07b
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥78.40b |
| Equity | JP¥160.93b |
| Total liabilities | JP¥708.00b |
| Total assets | JP¥868.93b |
Recent financial health updates
No updates
Recent updates
Is There An Opportunity With Sumitomo Pharma Co., Ltd.'s (TSE:4506) 38% Undervaluation?
Sep 12
There's No Escaping Sumitomo Pharma Co., Ltd.'s (TSE:4506) Muted Revenues Despite A 26% Share Price Rise
Aug 16A Piece Of The Puzzle Missing From Sumitomo Pharma Co., Ltd.'s (TSE:4506) 28% Share Price Climb
Jun 26Is Sumitomo Pharma Co., Ltd. (TSE:4506) Trading At A 34% Discount?
May 13Market Cool On Sumitomo Pharma Co., Ltd.'s (TSE:4506) Revenues
Apr 17Financial Position Analysis
Short Term Liabilities: 4506's short term assets (¥325.9B) do not cover its short term liabilities (¥498.4B).
Long Term Liabilities: 4506's short term assets (¥325.9B) exceed its long term liabilities (¥209.6B).
Debt to Equity History and Analysis
Debt Level: 4506's net debt to equity ratio (193.7%) is considered high.
Reducing Debt: 4506's debt to equity ratio has increased from 6.2% to 242.4% over the past 5 years.
Debt Coverage: 4506's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 4506's interest payments on its debt are well covered by EBIT.